This HTML5 document contains 147 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62023144
rdf:type
wikibase:Item
schema:description
scientific article published in September 2018 научная статья vitenskapelig artikkel videnskabelig artikel article scientifique artigo científico 2018年学术文章 научни чланак 2018年学术文章 2018年學術文章 наукова стаття, опублікована у вересні 2018 2018 nî lūn-bûn מאמר מדעי artikulong pang-agham tieteellinen artikkeli article científic 2018年學術文章 vedecký článok artículo científico publicado en 2018 vědecký článek artigo científico επιστημονικό άρθρο 2018年学术文章 articolo scientifico 2018年學術文章 article scientific naučni članak مقالة علمية نشرت في سبتمبر 2018 2018年の論文 scientific article published in September 2018 บทความทางวิทยาศาสตร์ vetenskaplig artikel wetenschappelijk artikel bilimsel makale научна статия artigo científico teaduslik artikkel 2018年学术文章 2018년 논문 wissenschaftlicher Artikel tudományos cikk scientific article published in September 2018 2018年學術文章 vitskapeleg artikkel bài báo khoa học সেপ্টেম্বর ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ 2018年学术文章 artículu científicu научни чланак სამეცნიერო სტატია artikull shkencor artykuł naukowy articol științific 2018年学术文章 scienca artikolo 2018年學術文章 artikel ilmiah
p:P577
wds:Q62023144-DB0AE45A-80D0-49AC-8DD4-AB1A0009F4E5
wdt:P577
2018-07-25T00:00:00Z
p:P407
wds:Q62023144-8AEBC8E5-EA8B-40FF-8C80-F0131CE933C8
wdt:P407
wd:Q1860
p:P2860
wds:Q62023144-9E53F79D-F638-43E2-B2FF-3876EE29B119 wds:Q62023144-DE59575A-C010-4D3A-A3AF-A02AA1EE9CF7 wds:Q62023144-C77989B8-8CFA-4EED-B05A-E87096166FE7 wds:Q62023144-B4FF3701-4F2C-4F4A-9551-46445E6F19AD wds:Q62023144-E449DFAA-18A9-4CCC-BAF7-3C99C23AEA7A wds:Q62023144-0B4F43EA-EBEC-4813-AF3D-A60BD4B422E7 wds:Q62023144-00C835DB-7F70-405E-B38C-89FFB8C59868 wds:Q62023144-3945D111-0CCD-4252-A7D3-84BD1BCC8FF8 wds:Q62023144-48F20252-60DB-4647-ACB0-4926AADAAEA0 wds:Q62023144-24B6C8CB-1354-411F-AD14-83FA6068BE52 wds:Q62023144-2C59C0CA-01AD-46F4-9C6B-8FA6DE11DF5F wds:Q62023144-6123C287-A55F-4F32-AAD7-05D3D7407FCB wds:Q62023144-4AD8E9CA-9315-42AF-B6D7-BBF47DE4742F
wdt:P2860
wd:Q35633788 wd:Q46689219 wd:Q35891920 wd:Q57235865 wd:Q61642884 wd:Q38404794 wd:Q53032502 wd:Q39738762 wd:Q33928068 wd:Q38803492 wd:Q64111108 wd:Q33834390 wd:Q36611713
p:P2093
wds:Q62023144-8F449A58-7C54-4BE1-A3A1-82EEA4CB2E7C wds:Q62023144-9B66C6E7-FCCA-4C0F-9B2F-8B57B0B68401
wdt:P2093
Alejandro Arana Clara Laguna
rdfs:label
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
skos:prefLabel
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
schema:name
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
p:P50
wds:Q62023144-1B03D00B-771D-48AD-8FB6-0A3D5D4C1D7E wds:Q62023144-0E15296B-00F7-4368-A2F1-171FE7404595 wds:Q62023144-A84CA590-A73B-4170-8EAF-D75B01731D57 wds:Q62023144-D33C7053-E6A3-4B43-95B1-BC607A6F59AE wds:Q62023144-92C9A476-3D6C-4AEC-A9CF-B770DBC1C6BB wds:Q62023144-55AAB53D-0903-4D70-A40E-B8729DE1677B wds:Q62023144-65CB55A3-F6DB-406F-AAB8-B87B4172A264 wds:Q62023144-7C4E8373-DD3A-407B-83C6-A283CCC82FBC wds:Q62023144-78EFEE79-6204-4A6D-9B03-B05B4524ED08 wds:Q62023144-2219099A-B3A3-41B5-899D-8342EDEE77EE wds:Q62023144-38A8DBF2-DEC7-4457-83C3-62CE55D10242
wdt:P50
wd:Q89686980 wd:Q57304882 wd:Q100940379 wd:Q114338156 wd:Q88611465 wd:Q90312439 wd:Q61861385 wd:Q117232970 wd:Q42266131 wd:Q57950356 wd:Q47658002
p:P1476
wds:Q62023144-AF3F48CD-185C-455E-851D-2D680D9D02A2
wdt:P1476
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
p:P304
wds:Q62023144-374507EF-0B1B-404D-82FA-6B14FF8EAAD6
wdt:P304
953-961
p:P31
wds:Q62023144-EA14AC47-8CB3-4E9D-A8C2-81374E56E519
wdt:P31
wd:Q13442814
p:P921
wds:Q62023144-50EEC73B-B35E-4D7F-A709-EA54A9BDED4C wds:Q62023144-8E3BAF5E-620F-4F42-9C2D-4598D6D3D1E8 wds:Q62023144-E5A5467E-254D-44EB-8B79-880A772A4E3B
wdt:P921
wd:Q258591 wd:Q158230 wd:Q34
p:P698
wds:Q62023144-5C78DAB2-91D5-4DEC-8B2B-4A23B9BB7EA8
wdtn:P698
n5:30043552
wdt:P698
30043552
p:P1433
wds:Q62023144-9D3079A9-C6E8-4E57-8E88-2BEE43DEEF4F
wdt:P1433
wd:Q15759496
p:P433
wds:Q62023144-CDA3B23C-4637-4945-8489-D424F8F858C4
p:P478
wds:Q62023144-9E614589-5A97-43E7-82D2-3CD6491B0EF8
wdt:P433
9
wdt:P478
27
p:P356
wds:Q62023144-0D754BBD-2422-4C22-988D-F77A03F36FC4
wdtn:P356
n12:PDS.4584
wdt:P356
10.1002/PDS.4584
p:P932
wds:Q62023144-43B0923A-DDA7-4838-ACF1-007520171428
wdt:P932
6175151